ADVIA Centaur High-Sensitivity Troponin I (TNIH)
by Siemens Healthcare Diagnostics, Inc.
510(k) K171274Ref 10994775Model IVDR_67_TTN_DUB-C_C_KIT_TnIH
Active
Valid until
Not listed
FDA recalls
None foundTrust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| European Union | CE/IVDR EUDAMED | Number0405686900809VV 00630414602929 | Date9 Jul 2026 | StatusActive |
| United States | GUDID listing GUDID | Number00630414602929 | Date10 Aug 2018 | StatusListed |
| United States | FDA 510(k)SESE 510(k) | NumberK171274 | Date12 Jul 2018 | StatusActive |
Certificates
EUDAMED lists no certificate for this device's Basic UDI-DI.
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
- European Union
- United States
Specification
- Trade Name
- ADVIA Centaur High-Sensitivity Troponin I (TNIH) EUDAMEDADVIA Centaur TNIH 500T Kit GUDID
- Generic Name
- Troponin I IVD, kit, chemiluminescent immunoassay
- Device Name
- IVDR_67_TTN_DUB-C_C_KIT_TnIH
- Model / Ref / Catalog
- 10994775, IVDR_67_TTN_DUB-C_C_KIT_TnIH
- Primary DI / UDI-DI
- 00630414602929
- Basic UDI-DI
- 0405686900809VV
- 510(k) Number
- FDA Product Code
- MMI
- EMDN Code
- W01021306 Troponin i/t
- GMDN Term
- Troponin I IVD, kit, chemiluminescent immunoassay
- Device Class
- Class C EUDAMEDClass II 510(k)GUDID
- Regulation
- 21 CFR Part 862.1215
- EU market of registration
- Germany
- Advisory Committee
- Clinical Chemistry
- FDA Decision
- SESE Substantially Equivalent
- GUDID distribution status
- In Commercial Distribution
Truth per registry
| Field | EUDAMED | 510(k) | GUDID |
|---|---|---|---|
| Device Class | Class C | Class II | Class II |
Overview
AI-generated summary, 18 Sep 2026
The ADVIA Centaur High-Sensitivity Troponin I (TNIH) is an immunoassay method for the quantitative measurement of cardiac troponin I in human serum or plasma. It is classified as an immunoassay device for troponin subunit analysis, designed to detect low concentrations of cardiac troponin I with high sensitivity.
This device is intended for use on the ADVIA Centaur XP and ADVIA Centaur XPT systems and is authorized under FDA 510K and IVDR regulations. It is supplied as a single-use reagent and requires no special storage conditions beyond those specified in the manufacturer’s instructions. The assay aids in clinical chemistry applications, particularly in the evaluation of acute myocardial infarction.
Other devices from Siemens Healthcare Diagnostics
Questions
AI-generated answers, 18 Sep 2026
What clinical applications is the ADVIA Centaur High-Sensitivity Troponin I (TNIH) primarily used for?
The ADVIA Centaur High-Sensitivity Troponin I (TNIH) is designed to quantitatively measure low concentrations of cardiac troponin I in human serum or plasma. Its high sensitivity makes it particularly useful in clinical chemistry for evaluating acute myocardial infarction, helping clinicians detect early signs of heart attacks with greater precision.
Is the ADVIA Centaur High-Sensitivity Troponin I (TNIH) a single-use or reusable device, and how should it be stored?
The ADVIA Centaur High-Sensitivity Troponin I (TNIH) is supplied as a single-use reagent. Storage requirements are standard and align with the manufacturer’s instructions—no special conditions are specified beyond typical laboratory storage guidelines for immunoassay reagents.
Which platforms or systems is this device compatible with, and how does that affect its use?
The ADVIA Centaur High-Sensitivity Troponin I (TNIH) is specifically intended for use on the ADVIA Centaur XP and ADVIA Centaur XPT systems. Compatibility with these platforms ensures seamless integration into clinical workflows designed for these analyzers, enabling accurate troponin I measurement as part of routine cardiac diagnostics.
What regulatory pathways does the ADVIA Centaur High-Sensitivity Troponin I (TNIH) follow, and what does that mean for its use?
The device is authorized under FDA 510(k) clearance and IVDR (In Vitro Diagnostic Regulation) compliance, confirming its adherence to stringent U.S. and European regulatory standards. This means it has undergone validation for safety, performance, and clinical utility, ensuring reliable results for diagnosing cardiac conditions like acute myocardial infarction.
Properties
Other properties (18)
- Sterile: No
- Single Use: No
- Implantable: No
- Contains Latex: No
- Microbial Substances: No
- Self Testing: No
- Near-Patient Testing: No
- Companion Diagnostics: No
- Surgical Instrument: No
- New Device: No
- Prescription Use: No
- Over-the-Counter: No
- Convenience Kit: No
- Combination Product: No
- HCT/P: No
- Premarket Exempt: No
- Serial Number: No
- Manufacturing Date: No